Application of accelerator mass spectrometry (AMS) in early drug development. Part 1. Background and procedures

被引:0
|
作者
Lipner, Grzegorz [1 ]
Grynkiewicz, Grzegorz [1 ]
机构
[1] Inst Farmaceuty, Zakladzie Chem, PL-01793 Warsaw, Poland
来源
PRZEMYSL CHEMICZNY | 2012年 / 91卷 / 03期
关键词
IN-VIVO; PHARMACOKINETICS; EXPERIENCE; FUTURE; VOLUNTEERS; NUCLEAR; MEIQX; MICE; DNA;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A review, with 40 refs., and fundamentals of combined applications of linear accelerator and high resolution mass spectrometer for detection of org. compds. containing suitable C-14 labels in femtomol concns. for studying pharmacokinetic parameters and metabolic fate of drugs from single sub-pharmacolog. dose.
引用
收藏
页码:314 / 318
页数:5
相关论文
共 50 条
  • [1] Application of accelerator mass spectrometry (AMS) in early drug development. Part 2. Synthesis and certification of 14C-labelled compounds
    Lipner, Grzegorz
    Luniewski, Wojciech
    Maruszak, Wioletta
    Grynkiewicz, Grzegorz
    PRZEMYSL CHEMICZNY, 2012, 91 (03): : 320 - 325
  • [2] Accelerator mass spectrometry (AMS) in drug development at GSK
    Young, Graeme
    Ellis, Will
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2008, 51 (5-6): : 251 - 251
  • [3] Development and application of accelerator mass spectrometry (AMS) in cancer research.
    Turteltaub, KW
    Dingley, K
    Chepanoske, CL
    Brown, K
    Vogel, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U11 - U11
  • [4] Advantage of accelerator mass spectrometry (AMS) for drug research
    Minamimoto, Ryogo
    Hamabe, Yoshimi
    Miyaoka, Teiji
    Oka, Takashi
    Matsui, Takao
    Inoue, Tomio
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [5] Application of accelerator mass spectrometry (AMS) to immunoassay.
    Shan, G
    Huang, W
    Gee, SJ
    Hammock, BD
    Buchholz, BA
    Vogel, JS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U118 - U118
  • [6] Application of accelerator mass spectrometry in drug development - vismodegib as a case study
    Hop, Cornelis
    Graham, Richard
    Wong, Harvey
    Dresser, Mark
    Khojasteh, Cyrus
    Shin, Young
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [7] Evaluation of microdosing strategies utilizing accelerator mass Spectrometry for pharmacokinetic studies in preclinical drug development.
    Sandhu, P
    Vogel, JS
    Rose, MJ
    Ubick, EA
    Brunner, JE
    Wallace, MA
    Adelsberger, JK
    Baker, MP
    Henderson, PT
    Pearson, PG
    Baillie, TA
    CHEMICAL RESEARCH IN TOXICOLOGY, 2004, 17 (12) : 1757 - 1758
  • [8] Evaluation of microdosing strategies utilizing accelerator mass spectrometry for pharmacokinetic studies in preclinical drug development.
    Sandhu, P
    Vogel, JS
    Rose, MJ
    Ubick, EA
    Brunner, JE
    Wallace, MA
    Adelsberger, JK
    Baker, MP
    Henderson, PT
    Pearson, PG
    Baillie, TA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U374 - U374
  • [9] Development and Application of Ultrasensitive Accelerator Mass Spectrometry
    Jiang S.
    Journal of Chinese Mass Spectrometry Society, 2019, 40 (05) : 401 - 415
  • [10] ELECTRONIC EXCHANGE SYSTEM TXE4A: PART 1. BACKGROUND TO THE DEVELOPMENT.
    Leggett, G.R.
    British Telecommunications Engineering, 1982, 1 (pt 3): : 172 - 175